Related Experiment Videos

Serum chromium and angiographically determined coronary artery disease

Clinical Chemistry
|April 1, 1978
PubMed

Insights

Higher chromium (Cr3+) levels are linked to healthier arteries. This study found significantly lower serum chromium in individuals with coronary artery disease compared to those with normal arteries.

Area of Science:

  • Cardiovascular Health
  • Trace Element Metabolism

Background:

  • Atherosclerosis is a prevalent cardiovascular disease.
  • Population studies suggest a link between lower chromium concentrations and increased atheromatous plaque formation.
  • Chromium (Cr3+) is an essential trace element involved in metabolic processes.

Purpose of the Study:

  • To investigate the relationship between serum chromium (Cr3+) levels and coronary artery disease (CAD).
  • To assess chromium's role in the context of established cardiovascular risk factors.

Main Methods:

  • Serum chromium (Cr3+), cholesterol, and triacylglycerol levels were measured in 32 subjects.
  • Coronary artery disease was assessed using cineangiography.
  • Chromium concentrations were analyzed in relation to disease presence and other risk factors.

Main Results:

  • Subjects with coronary artery disease had significantly lower serum chromium concentrations than those with normal arteries.
  • A threshold of 5.50 microgram/liter of chromium distinguished subjects with and without significant coronary artery disease.
  • Chromium levels showed an inverse relationship with the prevalence of atheromatous plaque.

Conclusions:

  • Serum chromium (Cr3+) may play a protective role in cardiovascular health.
  • Lower chromium levels are associated with increased risk and presence of coronary artery disease.
  • Further research is warranted to elucidate chromium's specific mechanisms in preventing atherosclerosis.

Related Concept Videos